Gene · 18
Papers2,776
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,776
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effects of UGT1A, CYP2C9/19 and ABAT polymorphisms on plasma concentration of valproic acid in Chinese epilepsy patients. | Pharmacogenomics | 2023 | 36718958 | PubTator, text mining | PubMed |
| Long-term plasticity of astrocytic phenotypes and their control by neurons in health and disease. | Essays Biochem | 2023 | 36695493 | PubTator, text mining | PubMed |
| CAFuncAPA: a knowledgebase for systematic functional annotations of APA events in human cancers. | NAR Cancer | 2023 | 36694725 | PubTator, text mining | PubMed |
| Aldehyde dehydrogenase in solid tumors and other diseases: Potential biomarkers and therapeutic targets. | MedComm (2020) | 2023 | 36694633 | PubTator, text mining | PubMed |
| Network pharmacology-based analysis of heat clearing and detoxifying drug JC724 on the treatment of colorectal cancer. | World J Gastrointest Oncol | 2023 | 36684054 | PubTator, text mining | PubMed |
| Alpha2-Adrenergic Receptors as a Pharmacological Target for Spike-Wave Epilepsy. | Int J Mol Sci | 2023 | 36674992 | PubTator, text mining | PubMed |
| The Expanding Role of Cancer Stem Cell Marker ALDH1A3 in Cancer and Beyond. | Cancers (Basel) | 2023 | 36672441 | PubTator, text mining | PubMed |
| The Generation of Human iPSC Lines from Three Individuals with Dravet Syndrome and Characterization of Neural Differentiation Markers in iPSC-Derived Ventral Forebrain Organoid Model. | Cells | 2023 | 36672274 | PubTator, text mining | PubMed |
| Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | J Biol Chem | 2023 | 36634849 | PubTator, text mining | PubMed |
| Glyphosate based-herbicide disrupts energy metabolism and activates inflammatory response through oxidative stress in mice liver. | Chemosphere | 2023 | 36608876 | PubTator, text mining | PubMed |
| Epigenetic dysregulation of articular cartilage during progression of hip femoroacetabular impingement disease. | J Orthop Res | 2023 | 36606425 | PubTator, text mining | PubMed |
| Antiseizure Medications for the Prophylaxis of Migraine during the Anti- CGRP Drugs Era. | Curr Neuropharmacol | 2023 | 36582062 | PubTator, text mining | PubMed |
| Corrigendum to "ABAT targeted by miR-183-5p regulates cell functions in liver cancer" [Int. J. Biochem. Cell Biol. 141 (2021) 106116]. | Int J Biochem Cell Biol | 2023 | 36521342 | PubTator, text mining | PubMed |
| Heterozygous GABAA receptor β3 subunit N110D knock-in mice have epileptic spasms. | Epilepsia | 2023 | 36495145 | PubTator, text mining | PubMed |
| The Reversal Characteristics of GABAergic Neurons: A Neurovascular Model. | J Biomech Eng | 2023 | 36445228 | PubTator, text mining | PubMed |
| Evolutionary implications of C2 photosynthesis: how complex biochemical trade-offs may limit C4 evolution. | J Exp Bot | 2023 | 36437625 | PubTator, text mining | PubMed |
| [Corrigendum] Role of 4‑aminobutyrate aminotransferase (ABAT) and the lncRNA co‑expression network in the development of myelodysplastic syndrome. | Oncol Rep | 2023 | 36416343 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| A Placebo-Controlled Randomized Trial of Vigabatrin in the Management of Acute Alcohol Withdrawal. | Alcohol Alcohol | 2023 | 36161306 | PubTator, text mining | PubMed |
| Investigation of cannabidiol's potential targets in limbic seizures. In-silico approach. | J Biomol Struct Dyn | 2023 | 36129109 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/18/papers?page=12